Fahr syndrome is defined by the presence of calcifications of the basal ganglia bilateral and symmetrical, particularly affecting patients with dysparathyroidism, more rarely pseudohypoparathyroidism (PHP). 1 The disease was first described and named by Fuller Albright and colleagues in 1942. 2 It is a heterogeneous group of disorders characterized by hypocalcemia, hyperphosphatemia, increased serum concentration of parathyroid hormone (PTH), and insensitivity to the biologic activity of PTH. 2 Several variants of PHP have been identified. The molecular defects in the GNAS gene encoding the alpha subunit of the stimulatory G protein (Gsα) contribute to at least 3 different forms of the disease: PHP type 1a, PHP type 1b, and pseudopseudohypoparathyroidism. 3 PHP-1 is further divided into three different subtypes: 1a, 1b, and 1c. 3 PHP-1c, which is identical to PHP-1a in terms of the presence of AHO and hormone resistance, but in contrast to PHP-1a, in vitro assessment of Gs-alpha protein activity, reveals no abnormality, and mutations of GNAS are usually not observed. 4 The exact prevalence of PHP is unknown 5 because the investigators did not confirm the clinical diagnosis of PHP by a molecular analysis for most of the patients.Herein, we report a case of Fahr syndrome which allowed the diagnosis of very rare GNAS mutation in familial pseudohypoparathyroidism type 1a.
| CASE PRESENTATIONA 31-year-old man was born at full term. There was a distant familial consanguinity. Followed since the age of 15 for recurrent convulsive seizures (initial etiological investigation was negative specifically the serum calcium level was strictly normal), put on anti-epileptic treatment. Recently, the patient has reported memory disorders, a brain magnetic resonance imaging (MRI) has been carried out and revealed the presence of basal ganglia calcification. The patient was referred to our department for further explorations.At admission, he was conscious with Glasgow Coma Scale of 15 points, afebrile, and had stable vital signs. He